These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32489563)

  • 41. Endurance exercise training protects against the upregulation of nitric oxide in the striatum of MPTP/probenecid mouse model of Parkinson's disease.
    Al-Jarrah M; Obaidat H; Bataineh Z; Walton L; Al-Khateeb A
    NeuroRehabilitation; 2013; 32(1):141-7. PubMed ID: 23422467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson's disease model of mice.
    Haeri P; Mohammadipour A; Heidari Z; Ebrahimzadeh-Bideskan A
    Anat Sci Int; 2019 Jan; 94(1):119-127. PubMed ID: 30159851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage.
    Viveros-Paredes JM; Gonzalez-Castañeda RE; Escalante-Castañeda A; Tejeda-Martínez AR; Castañeda-Achutiguí F; Flores-Soto ME
    Neurologia (Engl Ed); 2019 Apr; 34(3):143-152. PubMed ID: 28104279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective role of 6-Hydroxy-1-H-Indazole in an MPTP-induced mouse model of Parkinson's disease.
    Xiao-Feng L; Wen-Ting Z; Yuan-Yuan X; Chong-Fa L; Lu Z; Jin-Jun R; Wen-Ya W
    Eur J Pharmacol; 2016 Nov; 791():348-354. PubMed ID: 27614126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson's disease mouse model.
    Zhou Y; Zhao WJ; Quan W; Qiao CM; Cui C; Hong H; Shi Y; Niu GY; Zhao LP; Shen YQ
    Brain Res Bull; 2021 Nov; 176():174-183. PubMed ID: 34478811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
    Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K
    J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
    Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL
    Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Glabridin attenuates MPTP-induced parkinson disease by inhibiting extracellular regulated protein kinases signaling pathway].
    Zhao Y; Lu ZN
    Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(26):2050-2054. PubMed ID: 28763878
    [No Abstract]   [Full Text] [Related]  

  • 54. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
    Zhu J; Dou S; Jiang Y; Chen J; Wang C; Cheng B
    Brain Res; 2019 Jul; 1715():203-212. PubMed ID: 30914252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
    Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
    J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A
    Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P; Ferger B
    Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model.
    Mandal S; Mandal SD; Chuttani K; Sawant KK; Subudhi BB
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1340-50. PubMed ID: 26710671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W; Sripanichkulchai K; Finkelstein DI
    Brain Res; 2006 Apr; 1084(1):28-37. PubMed ID: 16564034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.